Results 121 to 130 of about 139,227 (225)

Cardiomyopathies: Current Treatment and Future Options

open access: yes
The reprint highlights different forms of cardiomyopathy, such as RBM20, filamin C, and lamin A/C cardiomyopathy. Diagnostic and new treatment options are presented in arrhythmogenic, hypertrophic, dilated, and restrictive cardiomyopathy.

core   +1 more source

Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy are linked to chromosome 1q42-43

open access: yes, 2000
Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy are linked to chromosome 1q42 ...
DANIELI, GIAN ANTONIO   +18 more
core   +1 more source

Understanding the Mortality Trends in Patients With Ventricular Arrhythmias and Cardiomyopathy: A 25‐Year Retrospective Analysis From 1999–2024

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 6, November 2026.
Central illustration depicting trends in demographics and differences in Ventricular Arrhythmias with Cardiomyopathy‐related Mortality among adults in the United States from 1999 to 2024. ABSTRACT Background Ventricular Arrhythmias (VA) associated with Cardiomyopathy (CM) continues to be the major cause of death.
Nosheen Pervaiz   +8 more
wiley   +1 more source

SURGELLA: A Scoping Review of Impella‐Assisted Hemodynamic Support in High‐Risk Non‐Cardiac Surgery

open access: yesArtificial Organs, Volume 50, Issue 11, Page 1532-1545, November 2026.
In selected patients with severe LV dysfunction, Impella‐supported non‐cardiac surgery may provide a temporary hemodynamic bridge to otherwise prohibitive procedures. Published evidence remains limited to a small number of highly selected cases, supporting technical feasibility rather than comparative benefit or generalizable safety.
Hussein Elghazaly   +6 more
wiley   +1 more source

Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy

open access: yes, 2015
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy, usually transmitted with an autosomal dominant trait, characterized by right ventricular myocyte loss with fibrofatty replacement [1] .
Pesarini, Gabriele   +4 more
core   +1 more source

Genetic Architecture of Pediatric Cardiomyopathies Assessed by Whole‐Exome Sequencing: Insights Into Early‐Onset and Syndromic Forms

open access: yesClinical Genetics, Volume 110, Issue 5, Page 622-626, November 2026.
Pediatric cardiomyopathies (CM) are a heterogeneous group of disorders. Their genetic basis remains poorly defined, particularly in children with early‐onset and apparently isolated forms. With a diagnostic yield of 62.7%, our findings suggest that whole‐exome sequencing could improve the diagnosis, genetic counseling, and clinical management of ...
Luana Giovannangeli   +18 more
wiley   +1 more source

Natural Course of Electrocardiographic Features in Arrhythmogenic Right Ventricular Cardiomyopathy and Their Relation to Ventricular Arrhythmic Events

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Electrocardiographic abnormalities are common in arrhythmogenic right ventricular cardiomyopathy and are included in the 2010 Task Force Criteria. Their time course, however, remains uncertain.
Anneli Svensson   +11 more
doaj   +1 more source

Chd4 and ThPOK cooperate to preserve structural and electrophysiological integrity of the adult heart through Sprr1a repression

open access: yesThe FEBS Journal, Volume 293, Issue 21, Page 6444-6466, November 2026.
Chd4/NuRD and ThPOK cooperate to maintain transcriptional repression and nuclear organization in adult cardiomyocytes. Chd4 loss reduces miR‐150‐5p, relieving repression of Sprr1a, while ThPOK loss further enhances Sprr1a activation, possibly through altered chromatin–lamina interactions.
Fadoua El Abdellaoui‐Soussi   +12 more
wiley   +1 more source

Clinical Outcomes After Catheter Ablation in Patients With Structural Heart Disease and Ventricular Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 11, Page 2651-2661, November 2026.
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto   +2 more
wiley   +1 more source

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 11, Page 2686-2697, November 2026.
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy